This trial studies how best to educate communities about liver cancer. Educating communities may combat rising liver cancer rates attributed to hepatitis B and C infection in Philadelphia by identifying neighborhoods with higher than expected rates of liver cancer and related risk factors.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT04272619.
PRIMARY OBJECTIVES:
I. Conduct a geographic scan of liver cancer and related risk factors (age, race/ethnicity) for the entire state of Pennsylvania (PA) by census tract in order to dually identify neighborhoods in Philadelphia with greater disease/disparity burdens than expected compared to the state and to inform where liver cancer-related educational interventions may be most needed.
II. To identify and/or establish community partnerships in “high-risk” areas to collaborate with, delivering and evaluating educational sessions.
OUTLINE:
Participants attend an educational session virtually or over the phone consisting of electronic educational handouts about liver cancer including risks of liver cancer, its symptoms, how liver cancer is diagnosed and receive a brochure with information about liver cancer. Participants also complete surveys over 10 minutes at baseline and after the educational session.
Trial PhaseNo phase specified
Trial Typehealth services research
Lead OrganizationFox Chase Cancer Center
Principal InvestigatorShannon Lynch
